BOD Science Ltd (BOD) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.175x

Based on the latest financial reports, BOD Science Ltd (BOD) has a cash flow conversion efficiency ratio of -0.175x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$900.22K ≈ $636.96K USD) by net assets (AU$-5.15 Million ≈ $-3.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BOD Science Ltd balance sheet independence to measure how much of total assets are equity-financed.

BOD Science Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how BOD Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BOD Science Ltd (BOD) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

BOD Science Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BOD Science Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Apex Resources Inc V:APX	0.017x
QMC Quantum Minerals Corp V:QMC	0.001x
Citrus Plant5-L TA:CTPL5	-0.014x
AGS Transact Technologies Limited NSE:AGSTRA	0.198x
Millennium Food-Tech LP TA:MIFT	N/A
Beauce Gold Fields Inc V:BGF	-0.059x
Public Policy Holding Company Inc LSE:PPHC	-0.107x
P/F Atlantic Petroleum CO:ATLA-DKK	0.006x

Annual Cash Flow Conversion Efficiency for BOD Science Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of BOD Science Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see BOD Science Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$-5.15 Million ≈ $-3.65 Million	AU$937.08K ≈ $663.04K	-0.182x	-205.79%
2024-06-30	AU$-5.32 Million ≈ $-3.76 Million	AU$-913.98K ≈ $-646.70K	0.172x	-97.87%
2023-06-30	AU$-703.36K ≈ $-497.67K	AU$-5.68 Million ≈ $-4.02 Million	8.072x	+770.07%
2022-06-30	AU$3.47 Million ≈ $2.45 Million	AU$-4.18 Million ≈ $-2.96 Million	-1.205x	-78.87%
2021-06-30	AU$8.66 Million ≈ $6.13 Million	AU$-5.83 Million ≈ $-4.13 Million	-0.674x	-0.44%
2020-06-30	AU$4.81 Million ≈ $3.40 Million	AU$-3.22 Million ≈ $-2.28 Million	-0.671x	+78.63%
2019-06-30	AU$2.07 Million ≈ $1.46 Million	AU$-6.48 Million ≈ $-4.59 Million	-3.137x	-177.39%
2018-06-30	AU$2.62 Million ≈ $1.85 Million	AU$-2.96 Million ≈ $-2.10 Million	-1.131x	-43.54%
2017-06-30	AU$3.00 Million ≈ $2.12 Million	AU$-2.36 Million ≈ $-1.67 Million	-0.788x	-1925.02%
2016-06-30	AU$5.52 Million ≈ $3.91 Million	AU$-214.91K ≈ $-152.07K	-0.039x	--

About BOD Science Ltd

AU:BOD Australia Drug Manufacturers - Specialty & Generic

Market Cap

$3.01 Million

AU$4.26 Million AUD

Market Cap Rank

#29449 Global

#1666 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.02

All Time High

AU$0.67